Medical disclaimer

Progesterone After Euploid Frozen Embryo Transfer: Memorial Şişli Hospital Study

In this retrospective study, women who received vaginal progesterone after a euploid frozen embryo transfer in a modified natural cycle had a live birth rate of 67.7 %, versus 59.1 % with no progesterone. The patients were treated at the Istanbul Memorial Hospital ART and Reproductive Genetics Center, which appears to be the same center that the authors list under the Memorial Şişli Hospital name in Istanbul.

8 min read

Prepared by Bookimed editorial team

Medical content and care coordination

Memorial Şişli Hospital
← All research summaries
Published research, not an individual patient story.

The source identifies treatment at the named clinic. Study results describe this cohort, not a predicted individual outcome.

Key takeaways

  • The study compared no progesterone, vaginal progesterone, and vaginal plus subcutaneous progesterone for luteal phase support (support of the weeks after embryo transfer).
  • Live birth rate was 59.1 % with no progesterone and 67.7 % in both progesterone groups.
  • Adding subcutaneous progesterone to vaginal progesterone gave no additional advantage, according to the authors.
  • The study was retrospective and ran at a single center, so these group results are not a forecast for any one patient.
  • Bookimed did not run this study. We summarize the published abstract only.

The question this study addresses

The authors reviewed women who had a single vitrified-warmed euploid blastocyst transfer (an embryo with a normal chromosome count, frozen and thawed) in a modified natural cycle between January 2014 and May 2023. They compared three luteal phase support approaches and report that both progesterone groups had higher pregnancy and live birth rates than the group without progesterone. The setting was the Istanbul Memorial Hospital ART and Reproductive Genetics Center, which appears to be the same center that the authors list as Memorial Sisli Hospital.

The situation
Women with infertility having a single frozen-thawed euploid blastocyst transfer in a modified natural cycle (mNC-FET).
The treatment
Luteal phase support with no progesterone, vaginal progesterone, or vaginal plus subcutaneous progesterone 25 mg/d.

What this evidence cannot establish

  • The design is a retrospective cohort at one center, so the groups were not assigned by chance and other factors may play a role.
  • The abstract does not give follow-up time, live birth counts, or complication data.
  • The patients were treated at the Istanbul Memorial Hospital ART center, which appears to be the same center the authors list under Memorial Şişli Hospital. The name differs between the abstract and the clinic profile, so confirm it with the clinic.

Patient groups in the published study

418 patients · Published study group

No progesterone luteal support

Indication
Infertility, modified natural cycle frozen-thawed euploid blastocyst transfer
Treatment
No luteal phase progesterone support (LPS-WP)

418 patients in the group without progesterone.

Women with infertility who had a single euploid blastocyst transfer in a modified natural cycle and did not receive progesterone afterward.

No progesterone was given in the luteal phase. This group served as the comparison.

  • Live birth rate

    59.1%

    418 patients · Study group

    not stated

  • Biochemical pregnancy rate

    70.8%

    418 patients · Study group

    not stated

  • Clinical pregnancy rate

    65.1%

    418 patients · Study group

    not stated

  • Ongoing pregnancy rate

    60.5%

    418 patients · Study group

    not stated

Limits of this evidence

  • Live birth counts, follow-up, and complications are not stated in the abstract.
  • This group was smaller than the other two groups, and the study was retrospective.

For a clinic assessment

  • Previous IVF and embryo transfer records, including any embryo chromosome test report.
  • Current medication list, including any hormone treatment.

1995 patients · Published study group

Vaginal progesterone luteal support

Indication
Infertility, modified natural cycle frozen-thawed euploid blastocyst transfer
Treatment
Vaginal progesterone luteal phase support (LPS-VP)

1995 patients in the vaginal progesterone group.

Women with infertility who had a single euploid blastocyst transfer in a modified natural cycle and received vaginal progesterone afterward.

Vaginal progesterone, given as gel 90 mg twice a day at first and later as vaginal progesterone 100 mg twice a day.

  • Live birth rate

    67.7%

    1995 patients · Study group

    not stated

  • Biochemical pregnancy rate

    80.3%

    1995 patients · Study group

    not stated

  • Clinical pregnancy rate

    73.7%

    1995 patients · Study group

    not stated

  • Ongoing pregnancy rate

    69.3%

    1995 patients · Study group

    not stated

Limits of this evidence

  • Live birth counts, follow-up, and complications are not stated in the abstract.
  • The abstract describes group results only, and they cannot be applied directly to one person.

For a clinic assessment

  • Previous cycle records showing the transfer protocol and the luteal support used.
  • Medical history summary, including allergies and past reactions to hormone products.

789 patients · Published study group

Vaginal plus subcutaneous progesterone luteal support

Indication
Infertility, modified natural cycle frozen-thawed euploid blastocyst transfer
Treatment
Vaginal plus subcutaneous progesterone 25 mg/d (LPS-VP+SC)

789 patients in the combined progesterone group.

Women with infertility who had a single euploid blastocyst transfer in a modified natural cycle and received both vaginal and subcutaneous progesterone.

Vaginal progesterone plus subcutaneous progesterone 25 mg/d.

  • Live birth rate

    67.7%

    789 patients · Study group

    not stated

  • Biochemical pregnancy rate

    79.2%

    789 patients · Study group

    not stated

  • Clinical pregnancy rate

    71.6%

    789 patients · Study group

    not stated

  • Ongoing pregnancy rate

    68.6%

    789 patients · Study group

    not stated

Limits of this evidence

  • Live birth counts, follow-up, and complications are not stated in the abstract.
  • The authors report no additional advantage from adding the subcutaneous injection.

For a clinic assessment

  • Records of any earlier injectable medication, if used.
  • Current medication list for the coordinator to pass to the clinic.

Results and limits of the study

Live birth rate was 59.1 % without progesterone, 67.7 % with vaginal progesterone, and 67.7 % with vaginal plus subcutaneous progesterone (p = 0.002). Biochemical pregnancy rates were 70.8 %, 80.3 %, and 79.2 %. Clinical pregnancy rates were 65.1 %, 73.7 %, and 71.6 %. Ongoing pregnancy rates were 60.5 %, 69.3 %, and 68.6 %. The authors also report that progesterone in the luteal phase was associated with a higher likelihood of live birth in a multivariable regression analysis.

Limitations and unknowns

  • The abstract does not say how long patients were followed.
  • The number of live births and other raw counts are not given.
  • Complications and side effects are not reported in the abstract.
  • It is not stated how the results would apply to a patient with a different age or history.

What to clarify in your treatment plan

Before booking, ask the clinic which luteal phase support it would use for a modified natural cycle transfer and why. Ask whether your embryos have had chromosome testing and what records the team needs from you. Also ask who will manage your care and how you can reach them after the transfer.

Memorial Şişli Hospital: clinic profile

  • The authors list the Memorial Sisli Hospital ART and Reproductive Genetics Center as their affiliation, and the abstract names the Istanbul Memorial Hospital ART and Reproductive Genetics Center as the setting, which appears to be the same center under another name.
  • The patients were treated at that center in Istanbul, so this is a single-center study from the clinic's own IVF unit.
  • The Memorial Şişli Hospital profile is available on Bookimed.
Memorial Şişli Hospital

Memorial Şişli Hospital

Istanbul, Turkey

4.6/5 · 437 Bookimed reviews (current clinic profile)

Semra Kahraman: doctor profile

  • Semra Kahraman is a listed author of the study (fifth author) and lists the Memorial Sisli Hospital ART and Reproductive Genetics Center as her affiliation.
Semra Kahraman

Semra Kahraman

Fertility specialist

34 years of experience

Safety and recovery: general information

General patient guidance, provided separately from the case evidence. Follow your treating team's instructions.

Possible side effects

  • Fertility medicine used to stimulate ovulation may cause ovarian hyperstimulation syndrome, where the ovaries can become large and painful and a treatment cycle may need to stop.

    Ask the clinic whether this applies to a frozen transfer in a modified natural cycle.

  • IVF may involve more than one baby, which can carry risks for you and your babies, and may involve an ectopic pregnancy, where the embryo implants outside the womb.

    Discuss with the doctor how the number of embryos transferred is decided.

Recovery and aftercare

  • A full IVF cycle can take around 3 to 6 weeks to complete, according to the NHS.

    Ask the clinic how long a frozen transfer cycle usually takes and how many days you should plan to stay in Istanbul.

Suitability and cautions

  • Some NHS-funded services may only offer IVF depending on age, weight, smoking, or whether you already have children.

    Ask the clinic about its own criteria.

  • Doctors may discuss specific IVF risks with women aged 40 and over.

    Share your age and history so the doctor can explain the risks that apply to you.

When to contact the clinic

  • You may need to contact the clinic if you have pain and bloating in your abdomen, feel sick, faint, or have vaginal bleeding or a brown watery discharge.

    Agree with the clinic in advance on who to contact and how.

  • You may need urgent help if you have difficulty breathing, chest or upper back pain, swelling, or pain at the tip of your shoulder.

    Seek urgent local medical care first and then inform the clinic.

Request a personal plan from the clinic

Ask Memorial Şişli Hospital for an IVF consultation and luteal support plan

The Bookimed coordinator can send your records to Memorial Şişli Hospital and request a consultation with the fertility team. The clinic decides on any treatment plan after reviewing your history.

Ask the clinic for a current, itemized quotation. Published evidence does not establish package inclusions or a current price.

Frequently asked questions

Who ran this study and where were the patients treated?

The study was run by authors who list the Memorial Sisli Hospital ART and Reproductive Genetics Center in Istanbul as their affiliation. The abstract says the patients were treated at the Istanbul Memorial Hospital ART and Reproductive Genetics Center, which appears to be the same center under a different name. Semra Kahraman is one of the authors. Bookimed did not run the study and only summarizes the published abstract.

Did progesterone improve live birth rates in this study?

Yes, in this study the live birth rate was higher with progesterone than without it. It was 67.7 % with vaginal progesterone and 67.7 % with vaginal plus subcutaneous progesterone, versus 59.1 % with no progesterone (p = 0.002). These are group results from a retrospective study and do not predict what will happen for an individual patient.

Does adding a subcutaneous progesterone injection help more?

According to the authors, no. Live birth rates were the same in the vaginal group and the vaginal plus subcutaneous group, both 67.7 %. The authors conclude that giving progesterone subcutaneously alongside vaginal progesterone does not offer any additional advantages. Ask your doctor which option suits your situation.

What does the abstract not tell us?

The abstract does not state follow-up time, the number of live births, or complications and side effects. It also does not say how results differ by age or other patient factors. Because the study is retrospective and from one center, its results may not apply to every patient. Ask the clinic to explain what is known for your own case.

Sources and scope

This page was prepared from the published abstract, its extracted results, and general medical information from the NHS. Bookimed did not run the study or review the full text.

  1. 1. Ozmen et al. – Comparison of three luteal phase support in cases with modified natural cycles cases undergoing euploid blastocyst transfers -Clinical trial.

    Retrospective single-center cohort study · 2025

    Women with infertility having single euploid blastocyst transfer in modified natural cycles, 2014 to 2023

    Follow-up: Not stated in the abstract

    Only the abstract was used, so details on follow-up, counts, and complications are missing.

  2. 2. NHS
  3. 3. Memorial Şişli Hospital on Bookimed
  4. 4. Semra Kahraman on Bookimed

Scope and limitations

  • A research summary is not an individual medical recommendation.
  • Group results describe the study participants, not a forecast for any one patient.

Related procedures

About the editorial team

Bookimed editorial team

Prepared by

Bookimed editorial team

Medical content and care coordination

Bookimed prepares evidence summaries from published medical sources and anonymized care records. The clinic and any doctors named on this page are identified separately in their own sections.

About this page

This page summarizes cited evidence and links to current Bookimed provider profiles. It does not replace an individual diagnosis or treatment plan. Published group results are not a guarantee of your outcome.

Clinic profiles and package availability come from the current Site catalog. Historical costs and research measurements keep their original context.

Report a correction